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Abstract 
Objectives: To investigate the validity and reliability of the Geriatric Anxiety Inventory in 
screening for anxiety in older inpatients post-stroke.  
Design: Longitudinal 
Subjects: A total of 81 inpatients with stroke aged 65 years or older were recruited at four 
centres in England. 
Main measures: At phase 1 the Geriatric Anxiety Inventory and the Hospital Anxiety and 
Depression Scale were administered and then the Structured Clinical Interview for Diagnostic 
and Statistical Manual of Mental Disorders 4th edition (phase 2). The Geriatric Anxiety 
Inventory was repeated a median of seven days later (phase 3). 
Results: Internal reliability of the Geriatric Anxiety Inventory was high (α = 0.95) and test-
retest reliability acceptable (τB = 0.53). Construct validity of the Geriatric Anxiety Inventory 
was evident with respect to the Hospital Anxiety and Depression Scale -Anxiety subscale (τB 
= 0.61).  At a cut off of 6/7, the sensitivity of the Geriatric Anxiety Inventory was 0.88 and 
specificity 0.84, with respect to Structured Clinical Interview diagnosis of anxiety. Hospital 
Anxiety and Depression Scale -Anxiety subscale sensitivity was 0.88, specificity 0.54 at the 
optimum cut off of 5/6. A comparison the areas under the curve of the Receiver Operating 
Characteristics for the two instruments indicated that the area under the curve of the Geriatric 
Anxiety Inventory was significantly larger than that of the Hospital Anxiety and Depression 
Scale –Anxiety subscale, supporting its superiority.  
Conclusions 
The Geriatric Anxiety Inventory is an internally consistent, reliable (stable) and valid 
instrument with acceptable sensitivity and specificity to screen for anxiety in older inpatients 
with stroke.  
 
 
Keywords: stroke, anxiety, screening 
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Introduction 
Stroke is associated with increased incidence of emotional difficulties (1,2). Prominent 
amongst these is anxiety. Estimates suggest anxiety affects 18% to 25% of people at any 
stage after stroke (3). Predictors of anxiety after stroke include stroke severity and cognitive 
impairment (4). Notably it is also associated with less good outcomes, for example reduced 
quality of life (5,6), social isolation (7) and reduced participation and functional ability (7,8).  
Thus, it is unsurprising that attention to anxiety after stroke has been recommended in clinical 
guidance (9).  
One issue that arises with respect to the consideration of anxiety after stroke, is how to 
identify it when it has many similar symptoms to stroke (e.g., physical tension, fatigue, 
problems concentrating), and where the majority of healthcare staff in regular contact with 
patients have only limited training in mental health. This requires the provision of screening 
instruments that are reliable and valid in people with stroke.  
A recent review (10) only identified one instrument that met acceptable psychometric criteria 
for screening for anxiety after stroke, the HADS-A (11). Since that review, an observational 
instrument has been developed and validated in stroke patients, the Behavioural Outcomes of 
Anxiety Scale (12,13), but the HADS-A remains the only recommended self-report tool that 
allows health care professionals to directly screen for anxiety after stroke. However, the 
HADS-A has been found to be difficult to use by many after stroke on account of its relative 
complexity (14); it requires those attempting to complete it to consider four different 
responses with respect to each of seven statements which patients choose to indicate how 
they have been feeling over the past week. It also has limitations with respect to its use with 
older people, who make up the majority of those with stroke. It is considered to lack a clear 
clinical cut off and to be more a measure of general distress than of anxiety (15,16). 
The aim of the study was to evaluate the validity and reliability of the GAI (17) a simple 
binary response instrument designed for use with older people, for screening for anxiety in of 
older inpatients with stroke. It was expected that the GAI would demonstrate construct 
validity, when compared to a gold standard clinical interview and with respect to the only 
other validated self-report instrument, the HADS-A. It was also expected the GAI would be 
internally consistent and stable over time (reliable) and ROCs could be used to identify 
optimum cut-offs with acceptable sensitivity and specificity. On the basis of its easier format 
it was thought participants would prefer the GAI over the HADS.  
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Methods 
Ethical approval was obtained from the South East Coast - Kent NHS National Research 
Ethics Service (REC12/LO/0256).  
Participants were recruited from four units providing inpatient rehabilitation for patients with 
stroke. Three of the stroke services were in the southeast of England, one was located in the 
Midlands. Participants were eligible for the study if they were inpatients, had suffered a 
stroke between 2 weeks and 6 months  previously, were 65 years or older, medically stable 
and gave informed consent. Exclusion criteria included having significant cognitive 
impairment as represented by a score < 8 on the Abbreviated Mental Test (18) or < 24 on the 
Mini Mental State Examination (19), or being regarded as having a significant cognitive 
impairment in the clinical opinion of the lead clinician. In addition patients were not 
approached if they were considered to have aphasia sufficient to prevent them from 
participating in an assessment, as ascertained by the lead clinician or speech and language 
therapist, or if they were considered to suffer from a co-morbid psychiatric disorder other 
than anxiety or depression, e.g. schizophrenia, dementia or a present psychotic episode, as 
identified in the medical notes. 
Measures used in the study included a Demographic Information Sheet, the Geriatric Anxiety 
Inventory, the Hospital Anxiety and Depression Scale, the Structured Clinical Interview for 
DSM-IV Axis 1 Disorders: Research Version. 
The Demographic Information Sheet collected background information on participants 
including age, gender, marital status, living circumstances, previous occupation, level of 
education, ethnicity, type and date of stroke, major diagnoses, current medication and major 
life events in the year prior to their stroke. 
The Geriatric Anxiety Inventory (17) is a 20-item self-report or administered scale that 
measures anxiety (over the last 7 days) in older people. Respondents either ‘agree’ or 
‘disagree’ to statements (e.g., ‘I worry a lot of the time’; ‘I get an upset stomach due to my 
worrying’). Research indicates that the GAI has good reliability and validity in both a 
‘normal’ sample of older people and in older people attending a psychogeriatric service (17). 
Scores range from 0 to 20. A cut-off point of 10/11 has been recommended within a 
psychogeriatric sample for detection of those with DSM-IV Generalised Anxiety Disorder. 
Sensitivity is .75 and specificity is .84 at this cut off in older adults (17). A recent review of 
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measures confirmed the GAI as appropriate for use with older people (16). The GAI has 
demonstrated sound psychometric properties in people with Parkinson’s disease (20). 
Hospital Anxiety and Depression Scale (HADS) [11]. The HADS was designed for to 
identify symptoms of anxiety and depression in hospitalised, medically ill patients. It is a 14 
item self-reported or clinician administered rating scale with two subscales, one measuring 
anxiety (HADS-A, 7 items) and the other depression (HADS-D, 7 items). Each item has four 
responses from which patients choose to indicate how they have been feeling over the past 
week. Item scores range from 0 to 3, with total scores for each subscale ranging from 0 to 21. 
Reliability and validity data are available for its use as a screening measure in stroke. 
O’Rourke et al. (21) found the HADS-A to have a sensitivity of .83 and specificity of .68 at a 
cut off of 6/7 for anxiety in a study of 111 stroke patients with reference to the Schedule for 
Affective Disorders and Schizophrenia – (SADS) (22). 
The Structured Clinical Interview for DSM-IV Axis 1 Disorders: Research Version (SCID-I-
RV) [23] is a semi-structured interview for making the major DSM-IV Axis I diagnoses. 
Structured clinical interviews are widely accepted as the gold standard for diagnosis of 
anxiety (24). After administering the overview section, specific sections of the SCID-I-RV 
were used to confirm a DSM-IV diagnosis of anxiety.  
Participants were identified by a designated lead clinician of the service. Eligible patients 
were approached by the lead clinician or senior staff member to see whether they were 
willing to receive study information.  Those who were willing to be involved were visited at 
least 24 hours later by a researcher to discuss the study further and to take consent. 
The study consisted of three 3 phases. In phase 1 (duration approximately 30 minutes) 
participants completed the GAI and the HADS with a trained researcher. The order of 
administration of these measures was counterbalanced to ensure that order effects were 
minimised. After administration participants were asked which screening measure they 
preferred to complete. Phase 2 of the study took about 45 minutes and consisted of the 
diagnostic interview; the overview and anxiety sections of the SCID-I-RV. The SCID-I-RV 
was administered by a different researcher from the one who conducted phase 1 and also 
blinded to the results of the screening measures. Phase 2 interviews took place between 24 
hours and one week after phase 1, with every attempt made for them to be completed as early 
as possible within this time frame. Demographic information not available in the medical 
notes was requested from the participant as part of this interview. In phase 3 (duration 
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approximately 15 minutes) the GAI was repeated in order to assess test-retest reliability. This 
phase was scheduled to take place as soon as practicable after phase 2.  
Using the point estimate approach of Shoukri, Asyali and Donner25 and general views on 
testretest reliability which suggest that figures around 0.7-0.8 are ‘good’26 and assuming an 
alpha in the region of at least 0.8 with an 95%CI surety that the alpha lies between 0.7 and 
0.9 (i.e. that it is at least ‘good’) it was determined a sample of at least 52 participants was 
required. Descriptive statistics were used to describe the study sample. The prevalence of 
anxiety was assessed by calculating the percentage of participants diagnosed as anxious by 
the Structured Clinical Interview. Cronbach’s alpha was used to establish internal consistency 
of the Geriatric Anxiety Inventory and Hospital Anxiety and Depression Scale. The scales 
were then assessed for skewness and kurtosis. Subsequently associations between the scales 
were assessed using Tau B, including phase1 Geriatric Anxiety Inventory scores with respect 
to phase 3 Geriatric Anxiety Inventory scores, to establish test re-test reliability. 
Receiver Operator Characteristic curves were calculated for the Geriatric Anxiety Inventory 
and Hospital Anxiety and Depression Scale – Anxiety subscale against the Structured 
Clinical Interview diagnosis. A Receiver Operator Characteristic curve plots sensitivity 
against false positive rate (1-specificity). The area under the curve provides a measure of 
overall performance of a screening instrument and represents the probability that a result for a 
randomly chosen positive case will exceed the result for a randomly chosen negative case. In 
this area a score of at least 0.80 is recommended for the sensitivity of a screening measure 
and test specificity is recommended to be at least 0.60 25. The Receiver Operator 
Characteristic curves were also used in order to explore the appropriate cut off points to 
identify a participant as anxious on the Geriatric Anxiety Inventory and on the Hospital 
Anxiety and Depression Scale – Anxiety subscale in relation to Structured Clinical Interview 
diagnosis. An Receiver Operator Characteristic curve evaluation was then undertaken to 
identify whether the Area Under the Curve achieved for the Geriatric Anxiety Inventory was 
significantly larger than that achieved by the Hospital Anxiety and Depression Scale – 
Anxiety subscale. Participant preference for a given screening instrument was considered by 
calculating the percentage of participants with respect to the following categories; ‘preference 
for Geriatric Anxiety Inventory’, ‘preference for Hospital Anxiety and Depression Scale – 
Anxiety subscale’ and ‘no preference’. A one-sample Chi-square test considering only those 
expressing a preference was conducted. 
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Results 
A total of 91 inpatients were recruited for the study between March 2013 and February 2015.  
Participant characteristics are summarized in Table 1. Median age was 79 (IQR = 14.5 yrs). 
Phase 1 data collection occurred at a median of 43 days after stroke (IQR = 39.5 days). The 
time between phase 1 and phase 2 was a median of 3 days (IQR = 5), time between phase 2 
and phase 3, a median of 3 days (IQR = 5), and time between phase 1 and phase 3, 7 days 
(IQR = 5.5). Sixty nine of 81 participants completed phase 2 (85%) and 53/81 (65%) phase 3. 
All loss to follow-up was on account of discharge from hospital. There was no statistical 
evidence those lost to follow-up differed from those retained on anxiety level or demographic 
variables. 
 
Insert table 1 about here 
 
Table 2 displays the distribution of scores on the GAI, the HADS-A, HADS-D and SCID-I-
RV. The DSM-IV criteria for Generalised Anxiety Disorder at phase 2 were met by 8/69 
(11.6%) participants. There were modest but significant correlations between years of formal 
education and anxiety; more education was associated with less anxiety (GAI τB = -.31, n = 
81, p < .01; HADS-A τB = -.32, p > .01. No other demographic characteristics were 
significantly associated with anxiety. GAI scores at phase 1 were positively skewed (skew = 
1.31, SE = .27, n = 81) with most participants reporting low levels of anxiety. This was also 
the case at phase 3 (skew = 1.76, SE = .30, n = 63). 
 
Insert table 2 about here 
 
The internal consistency of the GAI (phase 1 ɑ = .95, phase 3 ɑ = .95), the HADS-A (ɑ = .83) 
and the HADS-D  (ɑ = .64) was acceptable. The GAI demonstrated acceptable test–retest 
reliability (τB = .53, n = 63, p < .001). As evident in Table 3, item if deleted statistics 
supported the inclusion of all the GAI questions. 
 
Insert Table 3 about here 
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Total scores on the GAI significantly correlated with the HADS-A, (τB = .61, n = 81, p < 
.001) supporting construct validity. Good discriminant validity was demonstrated by this 
figure being much higher than the association with the HADS-D (τB = .28, n = 81, p = .001). 
This suggests that the GAI is a more valid measure of anxiety than depression. 
Figure 1 displays the ROC curve for the GAI and the HADS-A with respect to the SCID 
diagnosis.  The optimum cut off on the GAI to detect anxiety was 6/7. At this level 
acceptable sensitivity (.88) and specificity (.84) were demonstrated providing evidence of 
convergent validity. The optimum cut off for the HADS-A was 5/6 which achieved an 
identical sensitivity of .88 but a lower specificity of .46. The GAI misclassified 10/61 
participants as having anxiety when this was not the case based on the SCID, the HADS-A 
however misclassified 28/61 participants.  Areas under the ROC curves (AUCs) were 
compared between the GAI and HADS-A following the non-parametric testing procedures 
outlined by DeLong et al. (26) and implemented in R in the pROC package (27). This 
indicated that the AUC of the GAI of .84 (95%CI .65 – 1.00) was significantly larger than 
that of the HADS-A (.75, 95%CI .53 - .96; Z = 1.76, p = 0.04, one-tailed).  
 
Inset Figure 1 about here 
 
A total of 39 (48%) of participants preferred to complete the GAI, 26 (32%) preferred the 
HADS-A and 16 (20%) expressed no preference. The difference between preferences for the 
GAI over the HADS-A was not significant, X2 = 2.60, df = 1, p = .107, however it is noted 
68% preferred the GAI or had no preference. 
 
Discussion 
The GAI was found to have acceptable internal consistency and test re-test reliability in a 
sample of older people with stroke in an inpatient setting. Discriminant validity with respect 
to depression was acceptable. The optimal cut-off for the GAI with respect to SCID diagnosis 
was 6/7. This is lower than in an older adult psychiatric sample (17), but is consistent with 
other studies of anxiety after stroke (22,28-30).  At this cut-off acceptable sensitivity and 
specificity was evident, and superior to the comparison instrument the HADS-A. The HADS-
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A has demonstrated higher specificity in other studies of people with stroke (22,28-30) 
however in none of these were participants restricted to older people. The current findings 
support the concerns expressed about the utility of the HADS-A when used with people aged 
65 years and over (15,16). 
This study used a structured clinical interview as the gold standard for anxiety. This was 
administered blind to, and regardless of, scores on the screening instruments. However there 
are a number of limitations to the study that need to be acknowledged  Firstly, the rate of 
anxiety identified was low (11.6 %) as compared to prevalence studies which suggest a rate 
of 18% via interview (3). However, this low rate is not surprising given a hallmark of anxiety 
is avoidance (31); patients with anxiety may have been less likely to agree to participate in 
research focusing on this issue. This focus was rarely the case in studies on which prevalence 
estimates are based (3). In addition anxiety is associated with cognitive impairment in people 
with stroke (4). Therefore some people with anxiety may have been excluded on this basis. 
Cognitive impairment exclusion criteria may not have been applied or may have been less 
rigorously applied in prevalence studies. Of further concern is that because of discharge from 
the hospital some 15% of study participants were lost from phase 1 to phase 2. These issues 
raise questions about the representativeness of the sample obtained and therefore the weight 
that might be placed on the current findings. Further the participants in this study were all 
inpatients, having relatively recently had a stroke. The results of this investigation may not 
apply to those in the community after stroke. Sensitivity and specificity have been found to 
vary at different time periods relative to certain cut offs after stroke (32). This is an important 
consideration as the high rate for anxiety after stroke is relatively stable over time (3).  
Further research is required to develop and improve scales like the GAI to better identify 
anxiety after stroke, particularly to reduce the false positive rate. In addition studies are 
needed of screening measures for those living in the community after stroke. Responsiveness 
to change in anxiety was not considered in the current evaluation. This is important to 
consider as treatments become available that can address this problem in older people after 
stroke (33-35). 
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Table 1  Participants’ characteristics at phase 1  
 
Characteristics n % 
Age in years 
65-74 
75-84 
85-94 
≥ 95 
 
25 
29 
26 
1 
 
30.9 
35.8 
32.1 
1.2 
Gender 
Men 
Women 
 
42 
39 
 
51.9 
48.1 
Married/partnered 
Yes 
No 
Missing 
 
41 
37 
  3  
 
52.6 
47.4 
3.7 
Place of residence at time of 
stroke 
Living at home 
Warden assisted 
Other 
 
 
70 
5  
6 
 
 
86.4 
6.2 
7.4 
Type of stroke 
Ischemic 
Haemorrhagic 
Missing 
 
68 
10 
3 
 
87.2 
12.8 
3.7 
Side of lesion 
Right 
Left 
Bilateral 
Other (spinal)  
 
43 
31  
 3 
 1 
 
53.1 
38.3 
3.7 
1.2 
Previous stroke 
Yes 
No 
Missing 
 
20 
58 
3 
 
25.6 
74.4 
3.7 
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   Measure  n            Mean                             SD         Range 
GAI Phase 1 81 4.41 5.80 0 – 20 
HADS-A 
Phase 1 
81 5.47 4.57 0 – 18 
HADS-D 
Phase 1 
81 5.33 3.56 0 – 16 
HADS Total 
Phase 1 
81 10.80 7.29 0 – 33 
GAI Phase 3 53 3.68 5.37 0 – 20 
     
 
Table 2 Summary of results of mood screening 
Note: GAI = Geriatric Anxiety Inventory, HADS-A = Hospital Anxiety and Depression Scale 
- Anxiety subscale, HADS-D = Hospital Anxiety and Depression Scale  - Depression 
subscale, HADS Total = Hospital Anxiety and Depression Scale  - Total Score (HADS-A + 
HADS-D). 
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Item 
number 
GAI phase 1          GAI phase 3 
 Proportion 
endorsing 
item 
(N=81) 
Corrected- 
item 
correlation 
Proportion 
endorsing 
item  
(n= 63) 
Corrected 
item total 
correlation 
1 29.6 .60 23.8 .65 
2 27.2 .53 15.9 .53 
3 21.0 .57 9.5 .65 
4 34.6 .62 36.5 .50 
5 21.0 .79 15.9 .75 
6 28.4 .68 20.6 .74 
7 18.5 .66 11.1 .58 
8 25.9 .65 30.2 .66 
9 21.0 .77 23.8 .73 
10 24.7 .84 22.2 .76 
11 32.1 .74 27.0 .69 
12 11.1 .57 7.9 .55 
13 12.3 .62 15.9 .75 
14 19.8 .52 20.6 .58 
15 21.0 .60 15.9 .53 
16 22.2 .80 15.9 .83 
17 16.0 .79 17.5 .72 
18 14.8 .49 6.3 .57 
19 16.0 .81 12.7 .79 
20 22.2 .75 19.0 .83 
 
 
Table 3 
 Geriatric Anxiety Inventory (GAI) item statistics.  
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Figure 1. Receiver Operating Characteristic (ROC) curves for the Geriatric Anxiety Scale 
(GAI) and the Hospital Anxiety and Depression Scale - Anxiety sub scale (HADS-A) with 
respect to anxiety diagnosis on the Structured Clinical Interview for the Diagnostic and 
Statistical Manual for Mental Disorders 4th Edn. (SCID). 
 
 
 
 
